Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MNEMOSYNE: Cognitive Effects of Adjuvant Endocrine Therapy in Breast Cancer
NCT00893061Phase 3Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Mar 2009
- Primary completion
- Apr 2012
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of anastrozole, exemestane and letrozole in breast cancer (2 arms), sponsored by Centre Oscar Lambret. Primary endpoint: Changes in verbal episodic memory performance at 6 months. Started Mar 2009; status: completed.
02
Drugs
anastrozoleexemestaneletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00893061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893061.